Direct and indirect recognition: the role of MHC antigens in graft rejection.

[1]  Simon,et al.  Role of organelle pH in tumor cell biology and drug resistance. , 1999, Drug discovery today.

[2]  L. Glimcher,et al.  CD8+ effector cells responding to residual class I antigens, with help from CD4+ cells stimulated indirectly, cause rejection of "major histocompatibility complex-deficient" skin grafts. , 1997, Transplantation.

[3]  G. Hämmerling,et al.  HLA-DM acts as a molecular chaperone and rescues empty HLA-DR molecules at lysosomal pH. , 1997, Immunity.

[4]  G. Hämmerling,et al.  How HLA-DM edits the MHC class II peptide repertoire: survival of the fittest? , 1997, Immunology today.

[5]  M. Moskalenko,et al.  T cell tolerance is influenced by concomitant T cell recognition of cross-reactive self-peptides. , 1996, Journal of immunology.

[6]  G. Benichou,et al.  Induction of T cell responses to a self-antigen following allotransplantation. , 1996, Transplantation.

[7]  H. Weiner,et al.  Mechanisms of Oral Tolerance by MHC Peptides , 1996, Annals of the New York Academy of Sciences.

[8]  Bradley Ja.  Indirect T Cell Recognition in Allograft Rejection , 1996 .

[9]  G. Benichou,et al.  The contribution of peptides to T cell allorecognition and allograft rejection. , 1996, International reviews of immunology.

[10]  N. Suciu-Foca,et al.  New approaches to specific immunomodulation in transplantation. , 1996, International reviews of immunology.

[11]  M. Sayegh,et al.  Role of indirect allorecognition in allograft rejection. , 1996, International reviews of immunology.

[12]  A. Rudensky,et al.  Requirement for peptide in alloreactive CD4+ T cell recognition of class II MHC molecules. , 1995, Journal of immunology.

[13]  J. Markmann,et al.  Survival Of Mhc‐Deficient Mouse Heterotopic Cardiac Allografts , 1995, Transplantation.

[14]  A. Rudensky,et al.  Intracellular assembly and transport of endogenous peptide-MHC class II complexes. , 1994, Immunity.

[15]  R. Jaenisch,et al.  Major Histocompatibility Complex Class I Deficiency Prolongs Islet Allograft Survival , 1993, Diabetes.

[16]  William Arbuthnot Sir Lane,et al.  Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles , 1993, The Journal of experimental medicine.

[17]  A. Rudensky,et al.  Studies on naturally processed peptides associated with MHC class II molecules. , 1993, Chemical immunology.

[18]  J. Markmann,et al.  Indefinite survival of MHC class I-deficient murine pancreatic islet allografts. , 1992, Transplantation.

[19]  A. Rudensky,et al.  Monoclonal antibody detection of a major self peptide. MHC class II complex. , 1992, Journal of immunology.

[20]  J. J. Rood,et al.  HLA‐DR peptide‐induced alloreactive T cell lines reveal an HLA‐DR sequence that can be both “dominant” and “cryptic”: evidence for allele‐specific processing , 1992, European journal of immunology.

[21]  J. V. Noort.  Peptides bound to MHC , 1992, Nature.

[22]  A. Rudensky,et al.  Sequence analysis of peptides bound to MHC class II molecules , 1991, Nature.

[23]  D. Anderson,et al.  T cells sensitized to synthetic HLA-DR3 peptide give evidence of continuous presentation of denatured HLA-DR3 molecules by HLA-DP , 1989, The Journal of experimental medicine.

[24]  M. Pescovitz,et al.  Effect of class II antigen matching on renal allograft survival in miniature swine , 1984, The Journal of experimental medicine.

[25]  R. Lechler,et al.  Restoration of immunogenicity to passenger cell-depleted kidney allografts by the addition of donor strain dendritic cells , 1982, The Journal of experimental medicine.

[26]  K. Lafferty,et al.  EFFECT OF ORGAN CULTURE ON THE SURVIVAL OF THYROID ALLOGRAFTS IN MICE , 1976, Transplantation.

[27]  M. Bevan.  Cross-priming for a secondary cytotoxic response to minor H antigens with H-2 congenic cells which do not cross-react in the cytotoxic assay , 1976, The Journal of experimental medicine.